middle.news
Clarity Pharmaceuticals Advances Prostate Cancer Imaging with First Phase III Patient
1:23am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Clarity Pharmaceuticals Advances Prostate Cancer Imaging with First Phase III Patient
1:23am on Monday 2nd of June, 2025 AEST
Key Points
First patient imaged in Phase III AMPLIFY trial for Cu-SAR-bisPSMA
Trial targets biochemical recurrence of prostate cancer with 220 participants
Cu-SAR-bisPSMA shows superior lesion detection and flexible imaging schedule
Manufacturing and supply chain prepared for US and Australian clinical sites
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CU6
OPEN ARTICLE